Simulation Study of cDNA Dataset to Investigate Possible Association of Differentially Expressed Genes of Human THP1-Monocytic Cells in Cancer Progression Affected by Bacterial Shiga Toxins-Reference-Cited by-同舟云学术

Simulation Study of cDNA Dataset to Investigate Possible Association of Differentially Expressed Genes of Human THP1-Monocytic Cells in Cancer Progression Affected by Bacterial Shiga Toxins

Published:2018-03-13 Issue: Volume:9 Page:
ISSN:1664-302X
Container-title:Frontiers in Microbiology
language:
Short-container-title:Front. Microbiol.

Author:

Muhammad Syed A.,Guo Jinlei,Nguyen Thanh M.,Wu Xiaogang,Bai Baogang,Yang X. Frank,Chen Jake Y.

Publisher

Frontiers Media SA

Subject

Microbiology (medical),Microbiology

Reference71 articles.

1. A variant in PNPLA3 associated with fibrosis progression but not hepatocellular carcinoma in patients with hepatitis C virus infection;Ali;Clin. Gastroenterol. Hepatol,2016

2. Identification of the first inhibitor of the GBP1:PIM1 interaction. Implications for the development of a new class of anticancer agents against paclitaxel resistant cancer cells;Andreoli;J. Med. Chem,2014

3. Evaluation of thymic stromal lymphopoietin (TSLP) and its correlation with lymphatic metastasis in human gastric cancer;Barooei;Med. Oncol,2015

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of liver fibrosis with extrahepatic cancer in steatotic liver disease patients with PNPLA3 I148M GG genotype;Cancer Science;2023-12-11

2. Values of OAS gene family in the expression signature, immune cell infiltration and prognosis of human bladder cancer;BMC Cancer;2022-09-26

3. Construction of miRNA‐lncRNA‐mRNA co‐expression network affecting EMT‐ mediated cisplatin resistance in ovarian cancer;Journal of Cellular and Molecular Medicine;2022-07-10

4. Oligoadenylate synthetases-like is a prognostic biomarker and therapeutic target in pancreatic ductal adenocarcinoma;Annals of Translational Medicine;2022-02

5. Prognostic characterization of OAS1/OAS2/OAS3/OASL in breast cancer;BMC Cancer;2020-06-19